Questions you can ask the study staff during your phone appointment:

Please note:
Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:

The research site does not treat COVID-19 patients and/or suspected COVID-19 patients.
The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
Hand sanitisers and masks as required are available at the research site.
The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19.
Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days and require a negative COVID test to return to work.
Interested participants will not be left waiting for a long period of time and will be quickly attended to.
Parking is available at or near the research site.
The study team encourages the use of personal vehicles, taxi or rideshare services rather than public transport. Travel expenses will be reimbursed or a voucher provided to compensate you for your potential travel expenses associated with attending.
Any participant with flu-like symptoms or who have been in any hotspot will be required to quarantine or have a COVID test and provide a negative result before attending visits.
The research site/institution is taking all precautionary measures to ensure the safety of the study participants.

Research Study on A Potential Treatment for Those with Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED)